Literature DB >> 7913414

The 6-kilobase c-erbB2 promoter contains positive and negative regulatory elements functional in human mammary cell lines.

M Grooteclaes1, F Pasleau, H Dijkmans, P Berzi, A Albert, R Winkler-Gol.   

Abstract

A 6-kilobase fragment extending at the 5'-end of the c-erbB2 protooncogene was isolated from a normal human lymphocyte genomic DNA library. The full-length fragment and five subfragments with identical 3'-ends were obtained by progressive unidirectional deletion from the 5'-end and were cloned in front of the luciferase reporter gene. The hybrid genes were analyzed for transcriptional activity in human mammary cell lines synthesizing low (HBL-100 and T-47D), moderate (MDA-MB-453), or high (BT-474) amounts of the c-erbB2 mRNA and were also analyzed in HeLa cells. Gene-specific expression was observed, indicating the presence of multiple cis-acting sequences in the c-erbB2 promoter. A major negative element is located in the -2- to -4-kilobase region. It is flanked on both sides by positive elements that display enhanced transcriptional activity in the BT-474 tumor cells only. While predominant in the low-expressing cells, the effect of the repressor appears to be overcome by the distal transactivator in the high-expressing BT-474 cells, resulting in a 15 to 50 times increase in luciferase activity relative to the HBL-100 and T-47D cells, respectively. Cell-specific expression relies on the trans-acting factors present in the different cell lines. The formation of cell-specific protein-DNA complexes was demonstrated by gel retardation assay.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7913414

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  7 in total

Review 1.  Transcriptional regulation of type I receptor tyrosine kinases in the mammary gland.

Authors:  N P Bates; H C Hurst
Journal:  J Mammary Gland Biol Neoplasia       Date:  1997-04       Impact factor: 2.673

2.  Identification of HTF (HER2 transcription factor) as an AP-2 (activator protein-2) transcription factor and contribution of the HTF binding site to ERBB2 gene overexpression.

Authors:  Douglas Vernimmen; Dominique Begon; Christophe Salvador; Stéphanie Gofflot; Madeleine Grooteclaes; Rosita Winkler
Journal:  Biochem J       Date:  2003-02-15       Impact factor: 3.857

3.  The antagonistic regulation of human MUC4 and ErbB-2 genes by the Ets protein PEA3 in pancreatic cancer cells: implications for the proliferation/differentiation balance in the cells.

Authors:  Valérie Fauquette; Michael Perrais; Sylvain Cerulis; Nicolas Jonckheere; Marie-Paule Ducourouble; Jean-Pierre Aubert; Pascal Pigny; Isabelle Van Seuningen
Journal:  Biochem J       Date:  2005-02-15       Impact factor: 3.857

4.  Heregulin negatively regulates transcription of ErbB2/3 receptors via an AKT-mediated pathway.

Authors:  Smita Awasthi; Anne W Hamburger
Journal:  J Cell Physiol       Date:  2014-11       Impact factor: 6.384

5.  A novel HER2 gene body enhancer contributes to HER2 expression.

Authors:  Q Liu; M V Kulak; N Borcherding; P K Maina; W Zhang; R J Weigel; H H Qi
Journal:  Oncogene       Date:  2017-10-16       Impact factor: 9.867

6.  Negative transcriptional control of ERBB2 gene by MBP-1 and HDAC1: diagnostic implications in breast cancer.

Authors:  Flavia Contino; Claudia Mazzarella; Arianna Ferro; Mariavera Lo Presti; Elena Roz; Carmelo Lupo; Giovanni Perconti; Agata Giallongo; Salvatore Feo
Journal:  BMC Cancer       Date:  2013-02-19       Impact factor: 4.430

7.  Different mechanisms are implicated in ERBB2 gene overexpression in breast and in other cancers.

Authors:  D Vernimmen; M Gueders; S Pisvin; P Delvenne; R Winkler
Journal:  Br J Cancer       Date:  2003-09-01       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.